Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agent

Angiogenesis is an essential process in tumor growth, invasion and metastasis. VEGF receptor 2 (VEGFR2) inhibitors targeting tumor angiogenic pathway have been widely used in the clinical cancer treatment. However, most of currently used VEGFR2 kinase inhibitors are multi-target inhibitors which mig...

Full description

Saved in:
Bibliographic Details
Main Authors: Zongru Jiang (Author), Li Wang (Author), Xuesong Liu (Author), Cheng Chen (Author), Beilei Wang (Author), Wenliang Wang (Author), Chen Hu (Author), Kailin Yu (Author), Ziping Qi (Author), Qingwang Liu (Author), Aoli Wang (Author), Jing Liu (Author), Guangchen Hong (Author), Wenchao Wang (Author), Qingsong Liu (Author)
Format: Book
Published: Elsevier, 2020-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available